Novartis Says Alcon Glaucoma Treatment Approved in EU

Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza eye drops suspension to decrease elevated intraocular pressure (IOP) in adults with open-angle glaucoma or ocular hypertension.
International Approvals